Mechanisms of bevacizumab-induced hypertension have been postulated to be due to reduced production of nitric oxide (NO) and increased endothelin-1, with VEGF inhibition production therefore leading to vasoconstriction [7]. This evidence concerns the gene VEGFA and hypertensive disorder.